Rectal cancer treatment often involves a combination of therapies. When possible,?surgery?is used to cut away the cancer cells. Other treatments, such as?chemotherapy?and?radiation therapy, may be used after?surgery?to kill any cancer cells that remain and reduce the risk that cancer will return.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Rectal Cancer Therapeutics industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Medicine
Surgery
Other
Market Segment by Product Application
Hospital
Clinic
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Eli Lilly and Company
Taiwan Liposome
Genentech
Sanofi-aventis Groupe
Merck
Bristol-Myers Squibb
Hutchison MediPharma
Seattle Genetics
Advaxis
Pfizer
AstraZeneca
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Rectal Cancer Therapeutics consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Rectal Cancer Therapeutics market by identifying its various subsegments.
3.Focuses on the key global Rectal Cancer Therapeutics manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Rectal Cancer Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Rectal Cancer Therapeutics submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Rectal Cancer Therapeutics Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Rectal Cancer Therapeutics Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Rectal Cancer Therapeutics Segment by Type
2.1.1 Medicine
2.1.2 Surgery
2.1.3 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Other
2.3 Global Rectal Cancer Therapeutics Market Comparison by Regions (2017-2027)
2.3.1 Global Rectal Cancer Therapeutics Market Size (2017-2027)
2.3.2 North America Rectal Cancer Therapeutics Status and Prospect (2017-2027)
2.3.3 Europe Rectal Cancer Therapeutics Status and Prospect (2017-2027)
2.3.4 China Rectal Cancer Therapeutics Status and Prospect (2017-2027)
2.3.5 Japan Rectal Cancer Therapeutics Status and Prospect (2017-2027)
2.3.6 Southeast Asia Rectal Cancer Therapeutics Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Rectal Cancer Therapeutics Industry Impact
2.5.1 Rectal Cancer Therapeutics Business Impact Assessment - Covid-19
2.5.2 Market Trends and Rectal Cancer Therapeutics Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Rectal Cancer Therapeutics Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Rectal Cancer Therapeutics Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Rectal Cancer Therapeutics Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Rectal Cancer Therapeutics Manufacturer Market Share
3.5 Top 10 Rectal Cancer Therapeutics Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Rectal Cancer Therapeutics Market
3.7 Key Manufacturers Rectal Cancer Therapeutics Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Rectal Cancer Therapeutics Industry Key Manufacturers
4.1 Eli Lilly and Company
4.1.1 Compan Detail
4.1.2 Eli Lilly and Company Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.1.3 Eli Lilly and Company 167 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Eli Lilly and Company News
4.2 Taiwan Liposome
4.2.1 Compan Detail
4.2.2 Taiwan Liposome Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.2.3 Taiwan Liposome Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Eli Lilly and Company News
4.3 Genentech
4.3.1 Compan Detail
4.3.2 Genentech Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.3.3 Genentech Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Genentech News
4.4 Sanofi-aventis Groupe
4.4.1 Compan Detail
4.4.2 Sanofi-aventis Groupe Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.4.3 Sanofi-aventis Groupe Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Sanofi-aventis Groupe News
4.5 Merck
4.5.1 Compan Detail
4.5.2 Sanofi-aventis Groupe Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.5.3 Merck Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Merck News
4.6 Bristol-Myers Squibb
4.6.1 Compan Detail
4.6.2 Bristol-Myers Squibb Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.6.3 Bristol-Myers Squibb Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bristol-Myers Squibb News
4.7 Hutchison MediPharma
4.7.1 Compan Detail
4.7.2 Hutchison MediPharma Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.7.3 Hutchison MediPharma Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Seattle Genetics
4.8.1 Compan Detail
4.8.2 Seattle Genetics Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.8.3 Seattle Genetics Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Seattle Genetics News
4.9 Advaxis
4.9.1 Compan Detail
4.9.2 Advaxis Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.9.3 Advaxis Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Advaxis News
4.10 Pfizer
4.10.1 Compan Detail
4.10.2 Pfizer Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.10.3 Pfizer Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Pfizer News
4.11 AstraZeneca
4.11.1 Compan Detail
4.11.2 AstraZeneca Rectal Cancer Therapeutics Product Introduction, Application and Specification
4.11.3 AstraZeneca Rectal Cancer Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 AstraZeneca News
5 Global Rectal Cancer Therapeutics Market Segment by Big Type
5.1 Global Rectal Cancer Therapeutics Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Rectal Cancer Therapeutics Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Rectal Cancer Therapeutics Revenue and Market Share by Big Type (2017-2022)
5.2 Medicine Sales Growth Rate and Price
5.2.1 Global Medicine Sales Growth Rate (2017-2022)
5.2.2 Global Medicine Price (2017-2022)
5.3 Surgery Sales Growth Rate and Price
5.3.1 Global Surgery Sales Growth Rate (2017-2022)
5.3.2 Global Surgery Price (2017-2022)
5.4 Other Sales Growth Rate and Price
5.4.1 Global Other Sales Growth Rate (2017-2022)
5.4.2 Global Other Price (2017-2022)
6 Global Rectal Cancer Therapeutics Market Segment by Big Application
6.1 Global Rectal Cancer Therapeutics Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Rectal Cancer Therapeutics Forecast
7.1 Global Rectal Cancer Therapeutics Revenue, Sales and Growth Rate (2022-2027)
7.2 Rectal Cancer Therapeutics Market Forecast by Regions (2022-2027)
7.2.1 North America Rectal Cancer Therapeutics Market Forecast (2022-2027)
7.2.2 Europe Rectal Cancer Therapeutics Market Forecast (2022-2027)
7.2.3 China Rectal Cancer Therapeutics Market Forecast (2022-2027)
7.2.4 Japan Rectal Cancer Therapeutics Market Forecast (2022-2027)
7.2.5 Southeast Asia Rectal Cancer Therapeutics Market Forecast (2022-2027)
7.2.6 Other Regions Rectal Cancer Therapeutics Market Forecast (2022-2027)
7.3 Rectal Cancer Therapeutics Market Forecast by Type (2022-2027)
7.3.1 Global Rectal Cancer Therapeutics Sales Forecast by Type (2022-2027)
7.3.2 Global Rectal Cancer Therapeutics Market Share Forecast by Type (2022-2027)
7.4 Rectal Cancer Therapeutics Market Forecast by Application (2022-2027)
7.4.1 Global Rectal Cancer Therapeutics Sales Forecast by Application (2022-2027)
7.4.2 Global Rectal Cancer Therapeutics Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Rectal Cancer Therapeutics Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Rectal Cancer Therapeutics Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Rectal Cancer Therapeutics
Figure Market Concentration Ratio and Market Maturity Analysis of Rectal Cancer Therapeutics
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Rectal Cancer Therapeutics Market Size by Big Type
Figure Global Market Share of Rectal Cancer Therapeutics by Big Type in 2021
Figure Medicine Picture (2017-2022)
Figure Surgery Picture (2017-2022)
Global Rectal Cancer Therapeutics Market Size by Big Application
Table Global Rectal Cancer Therapeutics Market Size by Application
Figure Global Rectal Cancer Therapeutics Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Rectal Cancer Therapeutics Comparison by Regions (M USD) (2017-2027)
Figure Global Rectal Cancer Therapeutics Market Size (Million US$) (2017-2027)
Figure North America Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure China Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Rectal Cancer Therapeutics Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Rectal Cancer Therapeutics Sales by Manufacturer (2017-2022)
Figure Global Rectal Cancer Therapeutics Sales Market Share by Manufacturer in 2021
Table Global Rectal Cancer Therapeutics Revenue by Manufacturer (2017-2022)
Figure Global Rectal Cancer Therapeutics Revenue Market Share by Manufacturer in 2021
Table Global Rectal Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Rectal Cancer Therapeutics Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Rectal Cancer Therapeutics Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Rectal Cancer Therapeutics Market
Table Key Manufacturers Rectal Cancer Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Eli Lilly and Company Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Eli Lilly and Company
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Taiwan Liposome Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Taiwan Liposome
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taiwan Liposome Recent Development
Table Genentech Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Genentech
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Genentech Main Business
Table Genentech Recent Development
Table Sanofi-aventis Groupe Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Sanofi-aventis Groupe
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi-aventis Groupe Main Business
Table Sanofi-aventis Groupe Recent Development
Table Sanofi-aventis Groupe Main Business
Table Sanofi-aventis Groupe Recent Development
Table Merck Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Merck
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Bristol-Myers Squibb Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Hutchison MediPharma Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Hutchison MediPharma
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hutchison MediPharma Main Business
Table Hutchison MediPharma Recent Development
Table Seattle Genetics Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Seattle Genetics
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Seattle Genetics Main Business
Table Seattle Genetics Recent Development
Table Advaxis Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Advaxis
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Advaxis Main Business
Table Advaxis Recent Development
Table Pfizer Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of Pfizer
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table AstraZeneca Company Profile
Table Rectal Cancer Therapeutics Product Introduction, Application and Specification of AstraZeneca
Table Rectal Cancer Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Figure Global Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Figure Global Rectal Cancer Therapeutics Revenue and Growth Rate (2017-2022)
Table Global Rectal Cancer Therapeutics Sales by Regions (2017-2022)
Figure Global Rectal Cancer Therapeutics Sales Market Share by Regions in 2021
Table Global Rectal Cancer Therapeutics Revenue by Regions (2017-2022)
Figure Global Rectal Cancer Therapeutics Revenue Market Share by Regions in 2021
Figure North America Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Figure Europe Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Figure China Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Figure Japan Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Figure Southeast Asia Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Figure Other Regions Rectal Cancer Therapeutics Sales and Growth Rate (2017-2022)
Table Global Rectal Cancer Therapeutics Sales by Big Type (2017-2022)
Table Global Rectal Cancer Therapeutics Sales Market Share by Big Type (2017-2022)
Figure Global Rectal Cancer Therapeutics Sales Market Share by Big Type in 2019
Table Global Rectal Cancer Therapeutics Revenue by Big Type (2017-2022)
Table Global Rectal Cancer Therapeutics Revenue Market Share by Big Type (2017-2022)
Table Global Rectal Cancer Therapeutics Revenue Market Share by Big Type in 2019
Figure Global Medicine Sales Growth Rate (2017-2022)
Figure Global Medicine Price (2017-2022)
Figure Global Surgery Sales Growth Rate (2017-2022)
Figure Global Surgery Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Rectal Cancer Therapeutics Sales by Big Application (2017-2022)
Table Global Rectal Cancer Therapeutics Sales Market Share by Big Application (2017-2022)
Figure Global Rectal Cancer Therapeutics Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Rectal Cancer Therapeutics Sales and Growth Rate (2022-2027)
Figure Global Rectal Cancer Therapeutics Revenue and Growth Rate (2022-2027)
Table Global Rectal Cancer Therapeutics Sales Forecast by Regions (2022-2027)
Table Global Rectal Cancer Therapeutics Market Share Forecast by Regions (2022-2027)
Figure North America Sales Rectal Cancer Therapeutics Market Forecast (2022-2027)
Figure Europe Sales Rectal Cancer Therapeutics Market Forecast (2022-2027)
Figure China Sales Rectal Cancer Therapeutics Market Forecast (2022-2027)
Figure Japan Sales Rectal Cancer Therapeutics Market Forecast (2022-2027)
Figure Southeast Asia Sales Rectal Cancer Therapeutics Market Forecast (2022-2027)
Figure Other Regions Sales Rectal Cancer Therapeutics Market Forecast (2022-2027)
Table Global Rectal Cancer Therapeutics Sales Forecast by Type (2022-2027)
Table Global Rectal Cancer Therapeutics Market Share Forecast by Type (2022-2027)
Table Global Rectal Cancer Therapeutics Sales Forecast by Application (2022-2027)
Table Global Rectal Cancer Therapeutics Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rectal Cancer Therapeutics
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Rectal Cancer Therapeutics Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Rectal Cancer Therapeutics Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Rectal Cancer Therapeutics Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Rectal Cancer Therapeutics Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Rectal Cancer Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Eli Lilly and Company
Taiwan Liposome
Genentech
Sanofi-aventis Groupe
Merck
Bristol-Myers Squibb
Hutchison MediPharma
Seattle Genetics
Advaxis
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)